Literature DB >> 10146984

Impact of drug usage review on drug utilisation.

J L Blackburn1.   

Abstract

Drug use review (DUR) programmes have been a component of efforts to improve prescribing practices in both the institutional and ambulatory care settings in various areas of the world. DUR provides the mechanism for developing standards, assessing current therapy, and implementing a specific intervention followed by reassessment of drug utilisation. A number of interventions aimed at improving drug prescribing practices have been included as components of the DUR process. At this time, face-to-face interaction with the prescriber has been shown to be the most effective intervention. However, DUR interventions have rarely been subjected to quality pharmacoeconomic evaluation. There is a need for future research to evaluate the effects of DUR programmes on overall healthcare outcomes.

Mesh:

Year:  1993        PMID: 10146984     DOI: 10.2165/00019053-199303010-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  51 in total

1.  Guidelines for the evaluation of antibiotic use in obstetrics and gynecology.

Authors:  J Brandvold; D R Miller
Journal:  Can J Hosp Pharm       Date:  1978 Sep-Oct

2.  Principles of educational outreach ('academic detailing') to improve clinical decision making.

Authors:  S B Soumerai; J Avorn
Journal:  JAMA       Date:  1990-01-26       Impact factor: 56.272

3.  Pharmacy-based antimicrobial-monitoring service.

Authors:  J R Berman; F K Zaran; M J Rybak
Journal:  Am J Hosp Pharm       Date:  1992-07

4.  Workshop on drug utilization review. A practitioner's point of view.

Authors:  D R Abernethy
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

5.  Workshop on drug utilization review. Introduction.

Authors:  W B Abrams
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

6.  Development of criteria for drug utilization review.

Authors:  D A Knapp
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

7.  Development and implementation of a comprehensive, criteria-based drug-use review program.

Authors:  M W Todd; T D Keith; M T Foster
Journal:  Am J Hosp Pharm       Date:  1987-03

8.  Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

Authors:  J Avorn; S B Soumerai
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

9.  Drug use review: operational definitions.

Authors:  M H Stolar
Journal:  Am J Hosp Pharm       Date:  1978-01

10.  Measurement of drug utilization in Sweden: methodological and clinical implications.

Authors:  U Bergman; F Sjöqvist
Journal:  Acta Med Scand Suppl       Date:  1984
View more
  5 in total

Review 1.  Drug utilisation studies as tools in health economics.

Authors:  J A Sacristán; J Soto
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

Review 2.  Cephalosporin utilisation review and evaluation.

Authors:  G M Misan; C Dollman; D R Shaw; N Burgess
Journal:  Pharmacoeconomics       Date:  1995-08       Impact factor: 4.981

Review 3.  Antimicrobial drug utilisation in hospitals in Italy and other European countries.

Authors:  L Guglielmo; R Leone; U Moretti; A Conforti; G P Velo
Journal:  Infection       Date:  1994       Impact factor: 3.553

4.  A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron.

Authors:  G Dranitsaris; D Warr; A Puodziunas
Journal:  Support Care Cancer       Date:  1995-05       Impact factor: 3.603

5.  Utilization of the Parenteral Morphine in Emergency Department using the Anatomical Therapeutic Chemical Classification/Defined Daily Doses (ATC/DDD) System.

Authors:  Farzad Bozorgi; Ebrahim Salehifar; Seyed Mohammad Hosseininejad; Siavash Moradi; Ghazaleh Janbazi; Aroona Chabra
Journal:  Bull Emerg Trauma       Date:  2020-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.